Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Prevention and Risk: Treatment With a New Emphasis on Relationships (PARTNER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03396367
Recruitment Status : Recruiting
First Posted : January 11, 2018
Last Update Posted : November 17, 2020
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Tyrel Starks, Hunter College of City University of New York

Brief Summary:
This research examines the efficacy of an individually-delivered intervention tailored for YMSM in relationships. The intervention - termed PARTNER - utilizes a brief (4 session) motivational interviewing format to target Pre-Exposure Prophylaxis (PrEP) uptake/adherence, HIV transmission risk behavior, and associated drug use.

Condition or disease Intervention/treatment Phase
Adherence, Medication Risk Reduction Drug Use Sex, Anal HIV/AIDS Behavioral: PARTNER Behavioral: Education Intervention Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 240 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Intervention to Reduce Drug Use and HIV Incidence Among High PrEP Priority Partnered YMSM
Actual Study Start Date : February 14, 2018
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS Medicines

Arm Intervention/treatment
Experimental: PARTNER Intervention
This intervention is a four-session intervention designed to increase PrEP uptake, increase PrEP adherence, and reduce drug use and HIV transmission risk behaviors of individuals in relationships.
Behavioral: PARTNER
The PATRNER intervention addresses, drug use, PrEP uptake/adherence, and HIV transmission risk by enhancing communication skills by integrating motivational interviewing and video-based communication skills training.

Active Comparator: Education Intervention
This intervention is a four-session intervention that discussed drug use and its effect on physiological social functioning.
Behavioral: Education Intervention
The Education intervention consists of a 4-session health education intervention that addresses sexual risk and substance use through a lecture and question and answer format.

Primary Outcome Measures :
  1. Number of drug use instances [ Time Frame: 12 Months ]
    Self Report

  2. Positive drug assays [ Time Frame: 12 Months ]
    Drug test via fingernail assay

  3. Pre-Exposure Prophylaxis (PrEP) uptake [ Time Frame: 12 Month ]
    Self Report

  4. Pre-Exposure Prophylaxis (PrEP) adherence [ Time Frame: 12 Months ]
    Dried blood spot (DBS) via Western Blot analysis

  5. Number of HIV transmission risk events [ Time Frame: 12 Months ]
    Self-report of condomless anal sex (CAS)

  6. Positive sexually transmitted infection (STI) test [ Time Frame: 12 Months ]
    STI test via urinalysis and rectal swab

Secondary Outcome Measures :
  1. Pre-Exposure Prophylaxis (PrEP) adherence [ Time Frame: 12 Months ]
    Via fingernail assay

  2. Effectiveness of intervention implementation [ Time Frame: 12 Months ]
    Qualitative analysis of intervention feedback interviews

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 29 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Both gender at birth and current self-identified gender must be male.
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 18 to 29 years of age (inclusive);
  • Main partner must be aged 18 or older.
  • Must be in a main partner relationship with another male (duration ≥ 1 months);
  • HIV-negative serostatus (confirmed by rapid test);
  • Recent (past 30 day) use of at least one of the substances identified as most commonly used by YMSM (marijuana, cocaine, methamphetamine, heroin or other opiates, MDMA, psychedelics, GHB, and/or ketamine);
  • Sexual behavior meeting CDC criteria for PrEP candidacy (TRB with a casual partner in the past 30 days or TRB with a non-monogamous or serodiscordant main partner).
  • Participants must reside in the NYC metro area
  • Ability to communicate in English

Exclusion Criteria:

  • Unstable, serious psychiatric symptoms (assessed by the Psychotic Disorder subsection of the Structured Clinical Interview for DSM-IV);
  • Current suicidal/homicidal ideation;
  • Evidence of gross cognitive impairment (a score of <24 on the mini-mental state examination)
  • A history of severe physical or sexual Intimate Partner Violence (IPV) victimization in the current relationship in which participants report not currently feeling "safe" in their relationship and/or coerced to participate in the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03396367

Layout table for location contacts
Contact: Tyrel J Starks, PhD 212-206-7919 ext 934
Contact: Rodrigo Valles, PhD 212-206-7919 ext 925

Layout table for location information
United States, New York
Center for HIV Educational Studies and Training; Hunter College Recruiting
New York, New York, United States, 10018
Contact: Rodrigo Valles, PhD    212-206-7919 ext 925   
Principal Investigator: Tyrel J Starks, PhD         
Sub-Investigator: Jeffrey T Parsons, PhD         
Sponsors and Collaborators
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA)
Layout table for investigator information
Principal Investigator: Tyrel J Starks, PhD Hunter College of City University of New York
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Tyrel Starks, Associate Professor of Psychology, Hunter College of City University of New York Identifier: NCT03396367    
Other Study ID Numbers: R01DA045613 ( U.S. NIH Grant/Contract )
R01DA045613 ( U.S. NIH Grant/Contract )
First Posted: January 11, 2018    Key Record Dates
Last Update Posted: November 17, 2020
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Tyrel Starks, Hunter College of City University of New York:
Drug Use
Additional relevant MeSH terms:
Layout table for MeSH terms
Acquired Immunodeficiency Syndrome
HIV Infections
Blood-Borne Infections
Communicable Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Slow Virus Diseases
Immunologic Deficiency Syndromes
Immune System Diseases